Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

PSMA-targeting immunotherapies presented at ASCO

June 21, 2004

Insegia chosen as trade name for G17DT

June 18, 2004

Polyvalent vaccine reported to improve survival in advanced melanoma

June 18, 2004

Pivotal phase III trial of Rencarex for renal cell carcinoma opens enrollment

June 17, 2004

Synergistic effects of IL-21 and rituximab in B-lymphoma cell lines

June 17, 2004

An EGF vaccine reported to improve survival in advanced lung cancer

June 17, 2004

Antitumor effects of CpG-7909 in several types of human cancer

June 17, 2004

Autologous Xcellerated T-cells show antitumor efficacy in phase I/II clinical trials

June 16, 2004

Preliminary data suggest epratuzumab plus rituximab is safe and effective in NHL

June 16, 2004

Phase I/II study for Merix's renal cancer vaccine

June 15, 2004

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...